ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Clinical Outcome on Kidney Retransplantation in Comparison with First Kidney Transplantation in Korea – Nationwide Cohort Study.

    J. Kim,1,2 T. Ban,1,2 B. Jung,1,2 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim.1,2

    1Transplantation Research Center, Seoul St. Mary's Hospital, Seoul, Republic of Korea; 2Internal Medicine, Seoul St. Mary's Hospital, Seoul, Republic of Korea.

    Due to the limitation of the survival of kidney allograft, increasing number of patients need to take re-transplantation (re-KT) after the first allograft failure. In…
  • 2016 American Transplant Congress

    Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    E. Miner,1 T. Atim,2 M. Mamven,2 N. Adjekughele,1 I. Lawal,3 H. Nadey,4 O. Egbuna.5

    1Surgery, Garki Hospital, Garki, FCT/Abuja, Nigeria; 2Clinical Sciences, University of Abuja, Gwagwalada, FCT/Abuja, Nigeria; 3Surgery, National Hospital Abuja, Central Area, FCT/Abuja, Nigeria; 4Transplantation, Imperial College, London, United Kingdom; 5Transplant Nephrology, Amgen Incorporated, Thousand Oaks, CA.

    Background;Renal transplantation is the treatment of choice for individuals with end stage renal disease (ESRD).Method; This is a retrospective review of eight live related renal…
  • 2016 American Transplant Congress

    Impact of Preformed Anti-HLA Antibodies in the Outcomes of Kidney Transplantation.

    S. Santos,1 J. Malheiro,1 M. Costa,2 A. Campos,1 S. Pedroso,1 M. Almeida,1 L. Martins,1 L. Dias,1 C. Henriques,1 A. Cabrita.1

    1Nephrology, Hospital Santo António, CHP, Porto, Portugal; 2Nephrology, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.

    Background:Anti-HLA antibodies are risk factors for acute and chronic rejection and allograft loss. Its detection represents a major advance and is widely used in organ…
  • 2016 American Transplant Congress

    Bone Allograft: An Unusual Cause of Sensitization.

    J. Bloch,1 V. Elsermans,2 F. Provôt,1 A. Lionet,1 L. Wajbrot-Houzé,3 C. Noel,1 M. Hazzan.1

    1Service de Néphologie et Transplantation, CHRU, Hopital Claude Huriez, Lille, France; 2Institut d'Immunologie, CHRU, Centre de Biologie et Pathologie, Lille, France; 3Service de Néphrologie, Centre Hospitalier de Béthune, Béthune, France.

    We report the case of a 33 year-old female patient who started hemodialysis in 2009 because of end stage renal disease of unknown etiology. When…
  • 2016 American Transplant Congress

    Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.

    L. Rostaing,1,2,3 A. Allal,1 H. Naciri Benami,1 Z. Abdulrahman,1 L. Esposito,1 F. Sallusto,1 N. Doumerc,1 X. Game,1 B. Debiol,1 N. Congy,1 N. Kamar.1,3,4

    1Néphrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France; 2INSERM U 563, CHU Purpan, Toulouse, France; 3Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; 4INSERM U1043 CNRS UMR 5282, CHU Purpan, Toulouse, France.

    Introduction: Many studies or registries particularly in Japan, but also in Western Europe, have shown that long-term results from ABO-incompatible (ABOi) living-kidney transplantation are as…
  • 2016 American Transplant Congress

    Incidence, Risk Factors, and Outcomes of Delayed Graft Function in Deceased Donor Kidney Transplantation in a Brazilian Center.

    A. Ribeiro,1 M. Helfer,2 O. Costa,2 A. Viccari,1 R. Manfro.1,2

    1Division of Nephrology, Renal Transplant Unit, Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; 2School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

    Background. A high incidence of delayed graft function (DGF), after deceased donor kidney transplantation, occurs in Brazil and the reasons for such finding have not…
  • 2016 American Transplant Congress

    Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function.

    C. Baek,1 H. Kim,1 W. Yang,1 D. Han,2 S.-K. Park.1

    1Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Republic of Korea; 2Department of Surgery, Asan Medical Center, Seoul, Republic of Korea.

    Background: The outcomes of transplantation have been improved, but more than 50% of kidney transplantation recipients were still reported to have renal function of chronic…
  • 2016 American Transplant Congress

    United States versus Australia: Is "Percentage Decline in Estimated Glomerular Filtration Rate" Truly a Surrogate Outcome in Graft Survival?

    K. Parker,2 A. Rice,1 A. Kirby,1 M. Pinion,1 K. Parker.2

    1Internal Medicine Division of Nephrology and Hypertension, East Carolina University, Greenville, NC; 2Internal Medicine, Vidant Medical Center, Greenville, NC.

    Purpose: A previous study conducted in Australia and New Zealand examined the utility of estimated glomerular filtration rate (eGFR) decline as a surrogate marker for…
  • 2016 American Transplant Congress

    Association Between GFR Decline and Long Term Outcome in Renal Transplantation.

    A. Delay,1 O. Moranne,2 N. Maillard,1 E. Alamartine,1 C. Mariat.1

    1Nephrology Department, CHU, Saint Etienne, France; 2Nephrology Department, CHU, Nimes, France.

    In renal transplantation, GFR decline is strongly associated to graft failure and patient death and thus could be an interesting proxy for clinical research. GFR…
  • 2016 American Transplant Congress

    Negative Impact of Anticardiolipid Antibodies on 1-Year Renal Allograft Estimated Glomerular Filtration Rate: A Cohort Study.

    M. Gauthier,1 F. Canoui Poitrine,2 S. Hue,3 D. Desvaux,4 T. Kofman,1 P. Lang,1 P. Grimbert,1 M. Matignon.1

    1Nephrology-Transplantation, APHP, Henri Mondor, Créteil, France; 2Public Health, APHP, Henri Mondor, Créteil, France; 3Immunology, APHP, Henri Mondor, Créteil, France; 4Anatomopathology, APHP, Henri Mondor, Créteil, France.

    In kidney transplant recipients, antiphospholipid positive tests without antiphospholipid syndrome (APS) were described up to 38% of patients and seem to be associated with thrombotic…
  • « Previous Page
  • 1
  • …
  • 1200
  • 1201
  • 1202
  • 1203
  • 1204
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences